Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)
Titel:
Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3)
Auteur:
Arendt, A.-M. Heubach, F. Maier, C. P. Giardino, S. Jung, G. Kowalewski, E. Rabsteyn, A. Amorelli, G. Seitz, C. Schlegel, P. Handgretinger, R. Lang, P.